# Clearwater Paper Corp: financial statements, quarterly

CLW · NYSE · CIK 1441236 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/clw.md) · [Financials](/companies/clw/financials.md) · [Filings](/companies/clw/filings.md) · [Insiders](/companies/clw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/clw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [269](/filings/0001504337-25-000005.md) | [259](/filings/0001504337-25-000017.md) | [344](/filings/0002011383-25-000020.md) | [393](/filings/0001441236-25-000008.md) | [387](/filings/0001504337-25-000005.md) | [378](/filings/0001441236-26-000025.md) | [392](/filings/0001628280-26-050159.md) | [399](/filings/0001628280-26-067282.md) | [386 d](/filings/0001441236-26-000007.md) | [360](/filings/0001441236-26-000025.md) | [375](/filings/0001628280-26-050159.md) | [385](/filings/0001628280-26-067282.md) |
| Cost of revenue | $m | [233 d](/filings/0001441236-26-000007.md) | [226](/filings/0001504337-25-000017.md) | [346](/filings/0002011383-25-000020.md) | [363](/filings/0001441236-25-000008.md) | [372 d](/filings/0001441236-26-000007.md) | [342](/filings/0001441236-26-000025.md) | [349](/filings/0001628280-26-050159.md) | [380](/filings/0001628280-26-067282.md) | [369 d](/filings/0001441236-26-000007.md) | [361](/filings/0001441236-26-000025.md) | [385](/filings/0001628280-26-050159.md) | [364](/filings/0001628280-26-067282.md) |
| Gross profit | $m | [35.9](/filings/0001504337-25-000005.md) | [33.3](/filings/0001504337-25-000005.md) | [(2.0)](/filings/0001504337-25-000005.md) | [30.1](/filings/0001504337-25-000005.md) | [14.7](/filings/0001504337-25-000005.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [31.4 d](/filings/0001441236-26-000007.md) | [28.1](/filings/0001504337-25-000017.md) | [30.3](/filings/0002011383-25-000020.md) | [31.6](/filings/0001441236-25-000008.md) | [26.7 d](/filings/0001441236-26-000007.md) | [28.9](/filings/0001441236-26-000025.md) | [26.1](/filings/0001628280-26-050159.md) | [24.7](/filings/0001628280-26-067282.md) | [21.1 d](/filings/0001441236-26-000007.md) | [20.6](/filings/0001441236-26-000025.md) | [21.1](/filings/0001628280-26-050159.md) | [20.1](/filings/0001628280-26-067282.md) |
| Operating income | $m | [2.4 d](/filings/0001441236-26-000007.md) | [(0.8)](/filings/0001504337-25-000017.md) | [(46.9)](/filings/0002011383-25-000020.md) | [(1.2)](/filings/0001441236-25-000008.md) | [(15.6) d](/filings/0001441236-26-000007.md) | [(4.0)](/filings/0001441236-26-000025.md) | [9.8](/filings/0001628280-26-050159.md) | [(55.4)](/filings/0001628280-26-067282.md) | [7.5 d](/filings/0001441236-26-000007.md) | [(10.4)](/filings/0001441236-26-000025.md) | [(23.9)](/filings/0001628280-26-050159.md) | [2.5](/filings/0001628280-26-067282.md) |
| Interest expense | $m | [2.7 d](/filings/0001441236-26-000007.md) | [1.7](/filings/0001504337-25-000017.md) | [9.9](/filings/0002011383-25-000020.md) | [13.0](/filings/0001441236-25-000008.md) | [7.4 d](/filings/0001441236-26-000007.md) | [3.4](/filings/0001441236-26-000025.md) | [3.9](/filings/0001628280-26-050159.md) | [4.5](/filings/0001441236-25-000008.md) | [6.0 d](/filings/0001441236-26-000007.md) | [4.7](/filings/0001441236-26-000025.md) | [5.0](/filings/0001628280-26-050159.md) | not reported |
| Income tax | $m | [0.2](/filings/0001504337-25-000005.md) | [0.5](/filings/0001504337-25-000017.md) | [(14.6)](/filings/0002011383-25-000020.md) | [(3.3)](/filings/0001441236-25-000008.md) | [(9.7)](/filings/0001504337-25-000005.md) | [(1.8)](/filings/0001441236-26-000025.md) | [1.9](/filings/0001628280-26-050159.md) | [(6.5)](/filings/0001628280-26-067282.md) | [(0.8) d](/filings/0001441236-26-000007.md) | [(3.7)](/filings/0001441236-26-000025.md) | [(8.6)](/filings/0001628280-26-050159.md) | [(2.9)](/filings/0001628280-26-067282.md) |
| Net income | $m | [17.6](/filings/0001504337-25-000005.md) | [17.2](/filings/0001441236-25-000008.md) | [(25.8)](/filings/0001441236-25-000008.md) | [5.8](/filings/0001441236-25-000008.md) | [199](/filings/0001504337-25-000005.md) | [(6.3)](/filings/0001628280-26-067282.md) | [2.7](/filings/0001628280-26-067282.md) | [(53.3)](/filings/0001628280-26-067282.md) | [38.3 d](/filings/0001441236-26-000007.md) | [(12.8)](/filings/0001628280-26-067282.md) | [(21.5)](/filings/0001628280-26-067282.md) | [(1.6)](/filings/0001628280-26-067282.md) |
| Diluted EPS | $ per share | [1.06](/filings/0001504337-25-000005.md) | [1.03](/filings/0001504337-25-000017.md) | [(1.55)](/filings/0002011383-25-000020.md) | [0.35](/filings/0001441236-25-000008.md) | [11.91](/filings/0001504337-25-000005.md) | [(0.38)](/filings/0001441236-26-000025.md) | [0.17](/filings/0001628280-26-050159.md) | [(3.30)](/filings/0001628280-26-067282.md) | not reported | [(0.80)](/filings/0001441236-26-000025.md) | [(1.33)](/filings/0001628280-26-050159.md) | [(0.10)](/filings/0001628280-26-067282.md) |
| Basic EPS | $ per share | [1.06](/filings/0001504337-25-000005.md) | [1.03](/filings/0001504337-25-000017.md) | [(1.55)](/filings/0002011383-25-000020.md) | [0.35](/filings/0001441236-25-000008.md) | [11.91](/filings/0001504337-25-000005.md) | [(0.38)](/filings/0001441236-26-000025.md) | [0.17](/filings/0001628280-26-050159.md) | [(3.30)](/filings/0001628280-26-067282.md) | not reported | [(0.80)](/filings/0001441236-26-000025.md) | [(1.33)](/filings/0001628280-26-050159.md) | [(0.10)](/filings/0001628280-26-067282.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [42.0](/filings/0001504337-25-000005.md) | [55.2](/filings/0001504337-24-000025.md) | [39.6](/filings/0001504337-24-000042.md) | [35.5](/filings/0001504337-24-000053.md) | [79.6](/filings/0001441236-26-000007.md) | [44.0](/filings/0001504337-25-000017.md) | [46.7](/filings/0002011383-25-000020.md) | [34.4](/filings/0001441236-25-000008.md) | [30.7](/filings/0001628280-26-067282.md) | [36.5](/filings/0001441236-26-000025.md) | [95.4](/filings/0001628280-26-050159.md) | [35.7](/filings/0001628280-26-067282.md) |
| Current assets | $m | [564](/filings/0001504337-25-000005.md) | [576](/filings/0001504337-24-000025.md) | [734](/filings/0001504337-24-000042.md) | [732](/filings/0001504337-24-000053.md) | [545](/filings/0001441236-26-000007.md) | [500](/filings/0001504337-25-000017.md) | [510](/filings/0002011383-25-000020.md) | [488](/filings/0001441236-25-000008.md) | [526](/filings/0001628280-26-067282.md) | [522](/filings/0001441236-26-000025.md) | [532](/filings/0001628280-26-050159.md) | [746](/filings/0001628280-26-067282.md) |
| Total assets | $m | [1,672](/filings/0001504337-25-000005.md) | [1,680](/filings/0001504337-24-000025.md) | [2,478](/filings/0001504337-24-000042.md) | [2,489](/filings/0001504337-24-000053.md) | [1,679](/filings/0001441236-26-000007.md) | [1,634](/filings/0001504337-25-000017.md) | [1,641](/filings/0002011383-25-000020.md) | [1,561](/filings/0001441236-25-000008.md) | [1,588](/filings/0001628280-26-067282.md) | [1,570](/filings/0001441236-26-000025.md) | [1,571](/filings/0001628280-26-050159.md) | [1,776](/filings/0001628280-26-067282.md) |
| Current liabilities | $m | [286](/filings/0001504337-25-000005.md) | [301](/filings/0001504337-24-000025.md) | [423](/filings/0001504337-24-000042.md) | [412](/filings/0001504337-24-000053.md) | [320](/filings/0001441236-26-000007.md) | [300](/filings/0001504337-25-000017.md) | [259](/filings/0002011383-25-000020.md) | [232](/filings/0001441236-25-000008.md) | [216](/filings/0001628280-26-067282.md) | [200](/filings/0001441236-26-000025.md) | [232](/filings/0001628280-26-050159.md) | [507](/filings/0001628280-26-067282.md) |
| Total liabilities | $m | [1,003](/filings/0001504337-25-000005.md) | [995](/filings/0001504337-24-000025.md) | [1,820](/filings/0001504337-24-000042.md) | [1,824](/filings/0001504337-24-000053.md) | [825](/filings/0001441236-26-000007.md) | [797](/filings/0001504337-25-000017.md) | [804](/filings/0002011383-25-000020.md) | [779](/filings/0001441236-25-000008.md) | [763](/filings/0001628280-26-067282.md) | [756](/filings/0001441236-26-000025.md) | [777](/filings/0001628280-26-050159.md) | [982](/filings/0001628280-26-067282.md) |
| Long-term debt | $m | [440](/filings/0001504337-25-000005.md) | [442](/filings/0001504337-24-000025.md) | [1,138](/filings/0001504337-24-000042.md) | [1,143](/filings/0001504337-24-000053.md) | [282](/filings/0001441236-26-000007.md) | [282](/filings/0001504337-25-000017.md) | [329](/filings/0002011383-25-000020.md) | [336](/filings/0001441236-25-000008.md) | [346](/filings/0001628280-26-067282.md) | [361](/filings/0001441236-26-000025.md) | [361](/filings/0001628280-26-050159.md) | [293](/filings/0001628280-26-067282.md) |
| Current portion of debt | $m | [0.0](/filings/0001504337-25-000005.md) | [0.9](/filings/0001504337-24-000025.md) | [5.2](/filings/0001504337-24-000042.md) | [7.4](/filings/0001504337-24-000053.md) | [0.6](/filings/0001441236-26-000007.md) | [0.6](/filings/0001504337-25-000017.md) | [0.6](/filings/0002011383-25-000020.md) | [0.6](/filings/0001441236-25-000008.md) | [0.6](/filings/0001628280-26-067282.md) | [0.6](/filings/0001441236-26-000025.md) | [0.6](/filings/0001628280-26-050159.md) | [275](/filings/0001628280-26-067282.md) |
| Shareholders' equity | $m | [669](/filings/0001441236-26-000007.md) | [685](/filings/0001441236-25-000008.md) | [659](/filings/0001441236-25-000008.md) | [665](/filings/0001441236-25-000008.md) | [855](/filings/0001628280-26-067282.md) | [837](/filings/0001628280-26-067282.md) | [837](/filings/0001628280-26-067282.md) | [783](/filings/0001628280-26-067282.md) | [825](/filings/0001628280-26-067282.md) | [814](/filings/0001628280-26-067282.md) | [794](/filings/0001628280-26-067282.md) | [794](/filings/0001628280-26-067282.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent, us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [65.7 d](/filings/0001441236-26-000007.md) | [59.2](/filings/0001504337-25-000017.md) | [21.1](/filings/0001504337-24-000042.md) | [16.2 d](/filings/0001441236-25-000008.md) | [(35.1) d](/filings/0001441236-26-000007.md) | [1.5](/filings/0001441236-26-000025.md) | [(28.2) d](/filings/0001628280-26-050159.md) | [34.0 d](/filings/0001628280-26-067282.md) | [5.0 d](/filings/0001441236-26-000007.md) | [0.5](/filings/0001441236-26-000025.md) | [69.0 d](/filings/0001628280-26-050159.md) | [30.6 d](/filings/0001628280-26-067282.md) |
| Capital expenditure | $m | [25.2 d](/filings/0001441236-26-000007.md) | [18.5](/filings/0001504337-25-000017.md) | [18.1](/filings/0001504337-24-000042.md) | [47.0 d](/filings/0001441236-25-000008.md) | [33.0 d](/filings/0001441236-26-000007.md) | [32.7](/filings/0001441236-26-000025.md) | [22.9 d](/filings/0001628280-26-050159.md) | [18.3 d](/filings/0001628280-26-067282.md) | [14.9 d](/filings/0001441236-26-000007.md) | [9.1](/filings/0001441236-26-000025.md) | [9.6 d](/filings/0001628280-26-050159.md) | [14.7 d](/filings/0001628280-26-067282.md) |
| Share repurchases | $m | [2.8 d](/filings/0001441236-26-000007.md) | [0.5](/filings/0001504337-25-000017.md) | [3.0](/filings/0001504337-24-000042.md) | [2.5 d](/filings/0001441236-25-000008.md) | [4.0 d](/filings/0001441236-26-000007.md) | [10.9](/filings/0001441236-26-000025.md) | [4.2 d](/filings/0001628280-26-050159.md) | [2.1 d](/filings/0001628280-26-067282.md) | [0.0 d](/filings/0001441236-26-000007.md) | [0.0](/filings/0001441236-26-000025.md) | [0.1 d](/filings/0001628280-26-050159.md) | [0.0 d](/filings/0001628280-26-067282.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.0](/filings/0001504337-25-000005.md) | [0.0](/filings/0001504337-25-000005.md) | [0.0](/filings/0001504337-25-000005.md) | [16.7](/filings/0002011383-25-000020.md) | [0.0](/filings/0001504337-25-000005.md) | [0.0](/filings/0001504337-25-000005.md) | [16.4](/filings/0001441236-26-000025.md) | [16.2](/filings/0001628280-26-050159.md) | [16.1](/filings/0001628280-26-067282.md) | [16.1](/filings/0001441236-26-000025.md) | [16.1](/filings/0001628280-26-050159.md) | [16.1](/filings/0001628280-26-067282.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,141,717 at 2026-10-23, from the cover of the [10-Q filed 2026-10-26](/filings/0001628280-26-067282.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 26, 2026, 16:23 ET. No prices; not investment advice.